Maito, Alfhaiser M.
HRN: 16-23-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/31/2023
06/07/2023
IV
70mg
Q8h
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes